EDAP TMS
Created in 1979
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
716 6,257Activities
Technologies
Entity types
Location
4 Rue du Dauphiné, 69120 Vaulx-en-Velin, France
Vaulx-en-Velin
France
Employees
Scale: 201-500
Estimated: 199
Engaged corporates
6
1 4Added in Motherbase
4 years, 11 months ago
healthtech Value proposition
Bringing New Horizons to Therapy
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, Research & Development, and EndometriosisOriginal language
Bringing New Horizons to Therapy
EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology.
By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion.
As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.
EDAP TMS - Global leader in therapeutic ultrasound
https://www.edap-tms.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Assurance Maladie Insurance, Government Administration | Assurance Maladie Insurance, Government Administration | Other 9 Jun 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Not capitalistic Not partnership Event 4 Jun 2023 | | |
 Région Auvergne-Rhône-Alpes National and local authorities, Government Administration | Région Auvergne-Rhône-Alpes National and local authorities, Government Administration | Not capitalistic Not partnership Event 14 Nov 2016 | | |
 General Electric Building supplies, Industrial Machinery Manufacturing | General Electric Building supplies, Industrial Machinery Manufacturing | Not capitalistic Partnership Not event 27 Mar 2015 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Not capitalistic Partnership Event 18 Oct 2018 14 Dec 2023 | | |
 Mairie de Bordeaux National and local authorities, Government Administration | Mairie de Bordeaux National and local authorities, Government Administration | Not capitalistic Not partnership Event 14 Apr 2015 | | |